Back
Day Range
$68.40
$71.27
52-Week Range
$28.33
$84.94
Volume
1,339,621
50D / 200D Avg
$72.52
/
$59.94
Prev Close
$68.54
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -18.5 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -145.3 | 3.9 |
| Rev Growth 5Y % | 63.8 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$99.85
+43.5%
Low: $83.00
High: $157.00
Forward EPS
-$1.95
Est. Revenue
920 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$8.89
$5.92 – $10.87
|
4.1 B | 6 |
| FY2029 |
$6.64
$4.42 – $8.12
|
3.3 B | 10 |
| FY2028 |
$3.70
$0.59 – $6.05
|
2.4 B | 15 |
Key Takeaways
Revenue grew 63.82% annually over 5 years — strong growth
Negative free cash flow of -447.01M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 62.44%
Capital efficient — spends only 0.22% of revenue on capex
Growth
Revenue Growth (5Y)
63.82%
Revenue (1Y)126.26%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-65.45%
Net Margin-145.26%
Op. Margin-113.35%
Safety
Debt / Equity
N/A
Current Ratio2.62
Interest Coverage-10.72
Valuation
P/E Ratio
-18.50
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 126.26% | Revenue Growth (3Y) | 634.64% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 63.82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 502.08M | Net Income (TTM) | -729.31M |
| ROE | N/A | ROA | -77.92% |
| Gross Margin | 94.37% | Operating Margin | -113.35% |
| Net Margin | -145.26% | Free Cash Flow (TTM) | -447.01M |
| ROIC | -65.45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.62 |
| Interest Coverage | -10.72 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -18.50 | P/B Ratio | N/A |
| P/S Ratio | 26.87 | PEG Ratio | -0.65 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 13.49B | Enterprise Value | 15.65B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 502.08M | 221.90M | 9.30M | 77.65M | 69.72M |
| Net Income | -729.31M | -535.76M | -643.20M | -481.18M | -562.54M |
| EPS (Diluted) | -3.79 | -2.88 | -3.95 | -3.35 | -3.90 |
| Gross Profit | 473.81M | 218.02M | 6.86M | 74.21M | 66.60M |
| Operating Income | -569.09M | -592.97M | -607.37M | -512.20M | -576.63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 936.03M | 919.34M | 546.38M | 623.04M | 1.01B |
| Total Liabilities | 3.01B | 2.38B | 1.89B | 1.87B | 1.88B |
| Shareholders' Equity | -2.08B | -1.47B | -1.35B | -1.25B | -870.41M |
| Total Debt | 2.73B | 1.73B | 1.74B | 1.72B | 1.73B |
| Cash & Equivalents | 570.12M | 681.10M | 375.94M | 376.69M | 393.77M |
| Current Assets | 753.68M | 720.69M | 477.59M | 548.85M | 888.86M |
| Current Liabilities | 287.97M | 154.40M | 143.84M | 121.43M | 135.07M |